Similar articles

• Serum screening for Down's syndrome. Widening the programme would be costly.

  Phillips A. Phillips A. BMJ. 1993 Aug 21;307(6902):501. doi: 10.1136/bmj.307.6902.501-b. BMJ. 1993. PMID: 8400947 Free PMC article. No abstract available.
• Down's screening: the right to informed choice.

  Fisher J. Fisher J. Nurs Stand. 2016 Oct 12;31(7):27. doi: 10.7748/ns.31.7.27.s24. Nurs Stand. 2016. PMID: 27762970
• Antenatal screening for Down's syndrome.

  Macri VJ, Clark R. Macri VJ, et al. BMJ. 1992 Sep 26;305(6856):768; author reply 771. doi: 10.1136/bmj.305.6856.768-b. BMJ. 1992. PMID: 1422338 Free PMC article. No abstract available.
• Antenatal screening for Down's syndrome.

  Wald NJ, Kennard A, Hackshaw A, McGuire A. Wald NJ, et al. J Med Screen. 1997;4(4):181-246. doi: 10.1177/096914139700400402. J Med Screen. 1997. PMID: 9494915 Review.
• [Blood markers in the prenatal diagnosis of Down's syndrome: the triple test].

  Ortega-Benito JM. Ortega-Benito JM. Med Clin (Barc). 1995 Sep 9;105(7):264-8. Med Clin (Barc). 1995. PMID: 7475469 Review. Spanish. No abstract available.